San Diego, CA, November 17, 2005 – More than 10 novel lupus research posters and abstracts funded by the LRI were introduced at the American College of Rheumatology (ACR) /Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting in mid-November. Thousands of scientists, rheumatologists, health professionals, media members, and others attended this major meeting at the San Diego Convention Center in southern California.
At least six LRI-funded research posters and abstracts from the grant recipients of 2002, and four from the group funded in 2004, were presented at the meeting. Among them were:
- Year 2004 LRI grant recipient Robert Clancy, PhD, who presented research findings from a cross-sectional study that indicates that atherosclerosis in African Americans, Asians, and Hispanics with lupus may be related to an altered distribution of the recently identified endothelial protein C receptor (EPCR).
- Year 2002 LRI grant recipient Joan Von Feldt, MD, who presented three posters, one on the potential of the imaging technology Electron Beam Computed Tomography in identifying lupus patients with premature atherosclerosis.
- Year 2001 and 2004 grant recipient Mary Crow, MD, who presented research findings indicating that inflammatory gene expression in lupus peripheral blood mononuclear cells (PBMC) occurs independently of activation of the interferon alpha pathway, and correlates with malar rash and the absence of hydroxycholorquine therapy.
- Year 2004 grant recipient Bevra H. Hahn, MD, who presented research indicating that a certain form of the normally "good" high density lipoprotein (HDL) cholesterol linked to cardiovascular health plays a counterproductive role in people with lupus and rheumatoid arthritis, promoting atherosclerosis and heart disease in many of these individuals. Dr. Hahn collaborated with, among others, Maureen McMahon, MD, who received the 2003 ACR REF/Lupus Research Institute Lupus Investigator Fellowship Award. Click here for full story.
About the Lupus Research Institute
Pioneering Discovery to prevent, treat and cure lupus. The Lupus Research Institute (LRI), the country’s only nonprofit organization singularly devoted to novel research in lupus, champions innovation, encourages scientific creativity and risks exploring uncharted territory to bring new scientific solutions to the complex and dangerous autoimmune disease of lupus. Founded by families and shaped by scientists, the Institute mandates sound science and rigorous peer review to uncover and support only the highest ranked novel research. Its bold and proven research strategy places the LRI at the forefront of lupus science as the Institute consistently achieves the breakthrough discoveries, novel insights and solid results that are changing the course of lupus research and bringing new hope to people with lupus nationwide.